PERSPECTA

News from every angle

← Back to headlines

N-able and Accendra Health Outline 2026 Financial Projections

N-able provided its 2026 revenue and adjusted EBITDA margin targets, while Accendra Health outlined its 2026 revenue and adjusted EBITDA projections, alongside plans for cost reductions and a CEO retirement.

10 Aug, 17:39 — 10 Aug, 17:39
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed4d ago

N-able outlines 2026 revenue of $539M-$542M while targeting ~30% adjusted EBITDA margin amid go-to-market transition

Read full article →

Related Stories

Jeff Bezos Consortium Acquires Minority Stake in Liverpool FC

46m ago

Jeff Bezos Consortium Acquires 30% Stake in Liverpool FC

51m ago

Luigi Mangione Pleads Guilty in UnitedHealthcare CEO Case

1h ago

Uber Plans to Deploy 2,000 Robotaxis in Europe

1h ago